Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Finckh

Showing results (21-30 of 225) with videos related to

Pageof 23
Sort By:
Nature Clinical Practice. Rheumatology|January 30, 2008
Primer: strengths and weaknesses of meta-analysisAxel Finckh, Martin R Tramèr
Annals of Internal Medicine|June 6, 2007
Anti-cyclic citrullinated peptide antibodies in the diagnosis of rheumatoid arthritis: bayes clears the hazeAxel Finckh, Matthew H Liang
Arthritis Research & Therapy|April 17, 2009
Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical reviewAndrea Rubbert-Roth, Axel Finckh
Rheumatic Diseases Clinics of North America|December 2, 2014
Prevention of rheumatic diseases: strategies, caveats, and future directionsAxel Finckh, Kevin D Deane
Annals of Internal Medicine|February 3, 2005
Cardiovascular risks of cyclooxygenase-2 inhibitors: where we stand nowAxel Finckh, Mark D Aronson
The Journal of Rheumatology|July 17, 2014
Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?Elena Ciubotariu, Cem Gabay, Axel Finckh, et al.
Revue Medicale Suisse|March 15, 2023
[Can we prevent the occurrence of Rheumatoid Arthritis in 2023?]Evangelia Passia, Aline Schläpfer, Axel Finckh
RMD Open|February 22, 2020
Measuring ACPA in the general population or primary care: is it useful?Axel Finckh, Delphine Courvoisier, Celine Lamacchia, et al.
European Journal of Hospital Pharmacy : Science and Practice|June 22, 2026
A pharmacist-led intervention to promote the uptake of an infliximab biosimilar by patients and physicians in a university hospital rheumatology unitMarion Duwez, Axel Finckh, Pascal Bonnabry
Revue Medicale Suisse|March 20, 2022
[Vaccine prevention in patients with rheumatic diseases]Axel Finckh, Gilles Eperon, Kim Lauper
Pageof 23

Showing results (21-30 of 225) with videos related to

Sort By:
Pageof 23
Nature Clinical Practice. Rheumatology|January 30, 2008
Primer: strengths and weaknesses of meta-analysisAxel Finckh, Martin R Tramèr
Annals of Internal Medicine|June 6, 2007
Anti-cyclic citrullinated peptide antibodies in the diagnosis of rheumatoid arthritis: bayes clears the hazeAxel Finckh, Matthew H Liang
Arthritis Research & Therapy|April 17, 2009
Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical reviewAndrea Rubbert-Roth, Axel Finckh
Rheumatic Diseases Clinics of North America|December 2, 2014
Prevention of rheumatic diseases: strategies, caveats, and future directionsAxel Finckh, Kevin D Deane
Annals of Internal Medicine|February 3, 2005
Cardiovascular risks of cyclooxygenase-2 inhibitors: where we stand nowAxel Finckh, Mark D Aronson
The Journal of Rheumatology|July 17, 2014
Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?Elena Ciubotariu, Cem Gabay, Axel Finckh, et al.
Revue Medicale Suisse|March 15, 2023
[Can we prevent the occurrence of Rheumatoid Arthritis in 2023?]Evangelia Passia, Aline Schläpfer, Axel Finckh
RMD Open|February 22, 2020
Measuring ACPA in the general population or primary care: is it useful?Axel Finckh, Delphine Courvoisier, Celine Lamacchia, et al.
European Journal of Hospital Pharmacy : Science and Practice|June 22, 2026
A pharmacist-led intervention to promote the uptake of an infliximab biosimilar by patients and physicians in a university hospital rheumatology unitMarion Duwez, Axel Finckh, Pascal Bonnabry
Revue Medicale Suisse|March 20, 2022
[Vaccine prevention in patients with rheumatic diseases]Axel Finckh, Gilles Eperon, Kim Lauper
Pageof 23